TARGET
saveCTLA-4
Cytotoxic T-lymphocyte-associated protein 4; immune checkpoint.
also known as: cd152, anti-ctla-4
drugs
0
catalysts
0
news
79
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- BioNTech pays $205M for FDA voucher to speed up ‘late-stage oncology pipeline’fiercebiotech · 8d ago
- BioNTech sees ‘limited’ benefit to ADC after phase 3 reveals modest efficacy, ILD casesfiercebiotech · 24d ago
- ESMO: After leak, Merck and Moderna post phase 3 cancer vaccine data earlyfiercebiotech · 29d ago
- ‘A two-way conversation with the tumor’: Researchers use ‘avatar’ to predict immunotherapy responsesfiercebiotech · 1mo ago
- 5 biggest venture capital raises of Q3 2026biospace · 1mo ago
- BioNTech says CTLA-4 drug nearly doubled survival times for lung cancerendpoints · 2mo ago
- Summit, BioNTech, more headline WCLC with next-gen lung cancer drugsbiospace · 2mo ago
- 5 drugmakers chasing Merck and Moderna in the cancer vaccine racebiospace · 2mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that